Catalyst Pharmaceuticals. Currently trading at $2.91, this stock is up 150%+ YTD on news that it is passing the regulatory requirements on a new drug that is focused on developing and commercializing therapies for people with rare debilitating diseases. The Company has three drugs in development: Firdapse, CPP-109 and CPP-115.
Also, analysts have given it a short term PT ranging from $4.50-6.00. I'm not saying that it will necessarily continue to rise, could be fun options play with serious yacht potential. Took on a long position a few weeks ago but am considering calls. Would like to hear what you guys think.
Submitted July 14, 2017 at 09:49AM by show_me_your_gainz http://ift.tt/2uZCxnv
No comments:
Post a Comment